-
Loosening the Lid on Intimate Partner Violence Detection
Your primary objective when raising suspicion of IPV isn’t to force a confession or urge patients to get out. Instead, it is to provide repeated, safe opportunities so patients can recognize their circumstances, avail themselves of resources, and make their own choices on their own timeline.
-
Next-Gen CT: Dark Oral Contrast Agents
Dark oral contrast offers a sharper, unambiguous window into GI disease—enhancing spatial visualization, optimizing radiation dosage, and uncovering hard-to-spot abdominal lesions.
-
Athletic Groin Pain—Beyond the Pubic Symphysis
Expanding your search field from nipples to knees ensures accurate diagnosis, helping athletes avoid unnecessary surgery and return to peak competition faster.
-
High-Yield CMR for Cardiac Amyloidosis
Looking beyond non-specific LV hypertrophy, confirm post-contrast timing before diagnosing “myocardium-first” darkening.
-
Hemorrhoid Embolization Precision Techniques
Fortune favors radial access, 900 µm Embozene for distal branch pruning, and micro-coil embolization positioned above the CCR to safely halt flow below the pubic ramus.
-
Dural Tears & Flow Voids in CSF Leaks
Clocking the flow void sign on T2 or STIR offers localization early in the workup—streamlining myelography and focusing treatment right there at the tear.
-
Peripheral Nerve Injury Grading on MR Neurography
Rend a Sunder: Severity scales with Sunderland—distinguishing mild lesions which resolve with rest from structural disruptions requiring surgery. It’s a spectrum, too.
-
MR vs. Fluoro Defecography in Pelvic Floor Imaging
A physical exam alone doesn’t always capture a pelvic floor disorder’s underlying dysfunction. Dynamic MR defecography does though, delivering high-yield multiplanar imaging that directly informs surgical decision-making.
-
AI Reimbursement Ain’t Intelligent, Yet.
The vast majority of the House of Radiology’s AI tools lack standard billing codes, clear ROI pathways, or permanent reimbursement mechanisms.
-
Pancreatic Neuroendocrine Tumor Imaging
Typically, functioning tumors present early vis à vis clinical symptoms. Meanwhile, non-functioning tumors show up later and larger and undergo necrotic degeneration.
